Anthim Solution
Product Images NDC 69604-204

2 FDA label images from Elusys Therapeutics, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Anthim (NDC 69604-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Elusys Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600 mg/6 mL Vial Label (Anthim 01)

600 mg/6 mL Vial Label (Anthim 01)
Label for Anthim (obiltoxaximab) Injection, 600 mg/6 mL (100 mg/mL) solution for intravenous infusion. The single-dose vial requires dilution prior to use. Manufacturer is Elusys Therapeutics, Inc. Storage instructions specify 2°C to 8°C, protection from light, and no freezing or shaking.*
FDA Label Image

600 mg/6 mL Carton Label (Anthim 02)

600 mg/6 mL Carton Label (Anthim 02)
Anthim (obiltoxaximab) Injection 600 mg/6 mL (100 mg/mL) solution for intravenous infusion in a single-dose vial. The label includes storage instructions to refrigerate at 2° to 8°C and warnings not to freeze or shake the product. Manufactured by Elusys Therapeutics, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.